|
Market Closed -
NSE India S.E.
07:05:10 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 509.10 INR | -0.62% |
|
+1.29% | -9.89% |
| 07-23 | Solara Active Pharma Sciences Limited, Q1 2027 Earnings Call, Jul 23, 2026 | |
| 07-23 | Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 20.5B 214M 185M 174M 158M 297M 302M 2.04B 798M 10.27B 805M 788M 34.16B | P/E 2024 |
-2.35x | P/E 2025 | 3,792x |
|---|---|---|---|---|---|
| Enterprise Value | 28.42B 297M 257M 241M 219M 412M 418M 2.82B 1.11B 14.24B 1.12B 1.09B 47.36B | EV / Sales 2024 |
1.76x | EV / Sales 2025 | 2.54x |
| Free-Float |
46.78% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Solara Active Pharma Sciences Limited
| 1 day | -0.62% | ||
| 1 week | +1.29% | ||
| Current month | -0.87% | ||
| 1 month | -11.93% | ||
| 3 months | -12.21% | ||
| 6 months | +4.57% | ||
| Current year | -9.89% |
| 1 week | 501.95 |  | 527 |
| 1 month | 471.55 | | 585 |
| Current year | 422 | | 620.35 |
| 1 year | 422 | | 712 |
| 3 years | 286 | | 882.8 |
| 5 years | 286 | | 1,749 |
| 10 years | 134.5 | | 1,859.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandeep Rao
CEO | Chief Executive Officer | - | 2025-02-20 |
Sarat Kumar
DFI | Director of Finance/CFO | - | 2025-02-20 |
Ajit Manocha
CTO | Chief Tech/Sci/R&D Officer | 74 | 2026-08-09 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2018-04-10 | |
| Director/Board Member | 58 | 2018-04-10 | |
| Director/Board Member | 75 | 2023-11-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/14/25 | Buy | Director | 1,000 | 0.0021% | ||
| 3/6/25 | Pronomz Ventures LLP
| Buy | Company | 13,600 | 0.0283% | |
| 3/4/25 | Pronomz Ventures LLP
| Buy | Company | 216,361 | 0.4503% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | +1.29% | -14.74% | +39.61% | 258M | |
| +1.03% | -3.26% | +70.73% | +121.66% | 1,052B | |
| +0.71% | +0.18% | +48.81% | +50.72% | 627B | |
| +0.37% | +0.87% | +21.08% | +66.73% | 441B | |
| +0.28% | -4.56% | +39.10% | +38.05% | 349B | |
| +0.78% | -2.68% | +23.13% | +37.32% | 287B | |
| +0.87% | -3.59% | -1.52% | +7.12% | 241B | |
| +0.29% | -0.23% | +42.25% | +57.76% | 224B | |
| -0.78% | -4.49% | -15.86% | -54.13% | 202B | |
| +0.26% | +4.29% | +17.61% | +81.40% | 172B | |
| Average | +0.21% | -0.50% | +23.06% | +44.62% | 359.54B | |
| Weighted average by Cap. | +0.51% | -0.63% | +39.93% | +64.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.89B 135M 116M 109M 99.44M 187M 190M 1.28B 502M 6.46B 506M 495M 21.48B | 12.84B 134M 116M 109M 99.05M 186M 189M 1.27B 500M 6.43B 504M 493M 21.39B |
| Net income | -5.67B -59.34M -51.23M -48.06M -43.78M -82.31M -83.45M -563M -221M -2.84B -223M -218M -9.46B | 5.4M 56.48K 48.76K 45.74K 41.66K 78.34K 79.42K 536K 210K 2.71M 212K 207K 9M |
| Net Debt | 9.3B 97.27M 83.98M 78.78M 71.76M 135M 137M 924M 362M 4.66B 365M 357M 15.5B | 7.92B 82.85M 71.52M 67.1M 61.11M 115M 117M 787M 308M 3.97B 311M 304M 13.2B |
Employees
1,775
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | ₹509.10 | -0.62% | 75,893 |
| 26-08-14 | ₹512.30 | -1.17% | 76,954 |
| 26-08-13 | ₹518.35 | +2.52% | 113,276 |
| 26-08-12 | ₹505.60 | -0.61% | 57,746 |
| 26-08-11 | ₹508.70 | -1.07% | 131,956 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SOLARA Stock
Select your edition
All financial news and data tailored to specific country editions
